<DOC>
	<DOCNO>NCT01955694</DOCNO>
	<brief_summary>This study conduct subject clinical diagnosis worsen chronic heart failure either type 2 diabetes mellitus ( DM ) without chronic kidney disease ( CKD ) moderate CKD alone treat evidence-based therapy heart failure ( HF ) least 3 month prior emergency presentation hospital use multi-center , randomize , adaptive , double-blind , double-dummy , comparator-controlled , parallel-group design . Primary objective study investigate efficacy [ percentage subject relative decrease N-terminal prohormone B-type natriuretic peptide ( NT-proBNP ) 30 % baseline Visit 10 ( Day 90 ) ] safety different oral dos BAY94-8862 give daily .</brief_summary>
	<brief_title>Phase IIb Safety Efficacy Study BAY94-8862 Subjects With Worsening Chronic Heart Failure Left Ventricular Systolic Dysfunction Either Type 2 Diabetes Mellitus With Without Chronic Kidney Disease Moderate Chronic Kidney Disease Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Subjects worsen chronic heart failure require emergency presentation hospital treatment intravenous ( IV ) diuretic hospital Subjects either type 2 DM moderate CKD Acute denovo heart failure acute inflammatory heart disease , e.g . acute myocarditis Acute coronary syndrome ( ACS ) ( elevate cardiac troponins cause ACS exclusion criterion ) last 30 day prior screen visit Cardiogenic shock Valvular heart disease require surgical intervention course study Subjects leave ventricular assistance device wait heart transplantation Stroke transient ischemic cerebral attack last 3 month prior screen visit Addison 's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>BAY94-8862</keyword>
	<keyword>MR antagonist</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Japanese patient</keyword>
</DOC>